Biotech Stocks

• The Indian biotech sector was valued at US $80 billion in 2022. It aims to reach US $150 billion by 2025 and US $300 billion by 2030.
• The Indian government allows 100% investment for greenfield projects and manufacturing medical devices and 74-100% for brownfield projects.
• Some of the popular biotech stocks in India are Dr. Reddy's, Syngene International, Biocon, Sun Pharma Advanced Research, and Wockhardt Ltd.
• Investing in biotech stocks is rewarding due to the sector's rapid growth and innovative advancements.
• India is a major supplier of low-cost drugs. Also, it is a prime location for affordable clinical trials.
   

Biotechnology is a rapidly growing sector in the Indian economy. It is often referred to as a "sunrise sector." The government agencies involved in overseeing the biotech industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India.

In 2022, the sector was valued at US $80 billion. Now, there are expectations to reach US $150 billion by 2025 and surpass US $300 billion by 2030. Moreover, the government of India supports the sector by automatically allowing 100% investment for new “greenfield” projects in pharmaceuticals. On the other hand, for “brownfield projects”, 74% investment is allowed automatically, while 100% investment is permitted through the government route for existing projects. Additionally, 100% investment is allowed automatically for manufacturing medical devices.

Being a booming sector with strong government support, investors can consider investing in the biotech stocks in India for growth and capital appreciation. Let’s understand what biotech stocks are and check out some of the popular biotechnology stocks in India.

Biotech stocks refer to shares of companies involved in the biotechnology industry. These companies work on several biological products in areas such as:

• Healthcare
• Pharmaceuticals
• Agriculture
• Food production, and
• Fuel production

It must be noted that the biotechnology sector in India is growing rapidly and holds a lot of promise. This makes investing in biotech stocks rewarding because these companies often lead the way in scientific breakthroughs and new treatments.

However, be aware that these companies are also considered riskier investments due to uncertainties related to:

• Clinical trials
• Regulatory approvals
• Competition in the market

Despite the risks, many investors find the potential for high growth and profits appealing. In India, there are several notable biotech stocks worth considering for investment.

Did you recently apply for an IPO? Learn how to check IPO allotment status.

Biotech companies are involved in scientific research. Also, they develop new technologies in the field of biotechnology. For a greater understanding, let’s see how they work:

• Research and Development (R&D): Biotech companies focus heavily on research to explore new areas of biology. They use their scientific knowledge to solve complex problems and discover new drugs and therapies. These companies have also developed new diagnostic methods and agricultural solutions.
• Drug discovery and development: These companies discover new drugs. They identify targets for treating diseases and create drug molecules. Moreover, these companies conduct clinical trials to test the safety and effectiveness of these drugs.
• Genetic engineering and biomanufacturing: Biotech firms use genetic engineering to modify organisms. This includes developing therapeutic proteins and enzymes. These companies also formulate new vaccines and agricultural products.
• Agricultural biotechnology: It is worth mentioning that most biotech companies work to improve crop yields and enhance disease resistance in plants. Thanks to their latest technologies, these companies aim to increase the ability of crops to withstand environmental stresses. To achieve these goals, mostly, they use genetic engineering and advanced breeding techniques.

Appropriate risk management is the key to stock market success. Learn about stop-loss order and see how it protects your capital.

The Indian biotech industry consists of some of the popular biotech stocks in India. Being a major hub for biotech research, it is an attractive option for those looking to invest in biotech stocks. Let’s see some key points to understand the Indian biotech sector:

In 2022, the Indian biotech industry surpassed US $80.12 billion. This surge marked a 14% increase from the previous year.
The industry aims to grow significantly with a target of US $150 billion by 2025 and US $300 billion by 2030.
 

India is one of the largest suppliers of low-cost drugs globally. Currently, we are exporting medicines to over 150 countries.
India is the 7th largest destination in the world for conducting affordable clinical trials.

Now, let’s have a look at some of biotechnology stocks in India (data as of August 5, 2024):

Dr. Reddy's Laboratories

It is the largest biotech company in India in terms of market capitalisation. Primarily, the company operates in the “Global Generics” segment. It produces and markets both prescription and over-the-counter drugs. Currently, Dr. Reddy has a portfolio of over 190 medicines and 60 active pharmaceutical ingredients (APIs). Moreover, the company's reach is extensive. Around 80% of its revenue is generated from international markets.

Syngene International

Syngene International is an Indian biotech company. It specialises in the early discovery and commercial manufacturing of large molecules. It offers integrated research and development (R&D) and manufacturing services for a wide range of sectors, such as pharmaceuticals, speciality chemicals, biotechnology, consumer goods, nutrition, and animal health. Moreover, its comprehensive capabilities support its clients in developing innovative solutions from initial discovery through to commercial production.

Biocon

Biocon focuses on creating novel drugs. The company specifically addresses diseases such as diabetes, cancer, and immune disorders. Some of its common business segments are generics, biosimilars, novel biologics, and research services.

Also, Biocon is committed to improving health outcomes across 120 countries. This way, the company is making significant strides in enhancing global healthcare through its innovative drug development and widespread reach.

Sun Pharma advanced research

Sun Pharma Advanced Research is the fourth largest generic pharmaceutical company globally. It boasts a revenue of US $5.1 billion. The company has facilities to undertake extensive research and develop complex pharmaceutical products, particularly in oncology, neurodegeneration, and immunology. Sun Pharma also has 40 state-of-the-art manufacturing facilities with a client base across 100 countries.

Wockhardt Ltd.

Wockhardt Ltd. is engaged in the manufacturing of pharmaceutical and bio-pharmaceutical formulations. It produces medicines for various therapeutic areas, including dermatology, osteoarthritis, cosmeceuticals, medical nutrition, and oncology. The company has comprehensive biotechnology capabilities. It includes gene cloning, development of production strains, purification, downstream processing, and market formulation. This way, Wockhardt delivers high-quality pharmaceutical solutions using its modern technologies and expertise.

Investing in the biotech stocks in India can be highly rewarding due to the sector's rapid growth and potential for innovation. It must be noted that some of the biotechnology stocks in India are Dr. Reddy's, Syngene International, Biocon, Sun Pharma Advanced Research, and Wockhardt Ltd. These companies lead the industry with their strong focus on research, drug discovery, and agricultural biotechnology.

Despite some risks associated with clinical trials and regulatory approvals, the Indian biotech industry continues to expand. Moreover, as a major global supplier of low-cost drugs and a prime location for affordable clinical trials, the Indian biotech sector offers promising opportunities for investors.

Do you wish to trade in agricultural commodities? Understand what is NCDEX in detail, its several advantages, and benefits.

Stock market trading consists of purchasing and selling stocks of businesses. This trade is conducted through stock exchange brokers. As an investor, you can easily place trade orders through these brokers who execute the trades for you. After trade confirmation, you receive ownership of the shares through settlement. The transactions made in the market are recorded on contract notes that brokers provide to their clients. These also contain details like fees, taxes, etc.
 

Share Pricing

Pricing in the stock market is determined by the market forces of demand and supply. The driving force behind a price increase is demand exceeding supply, and vice versa. Stock exchanges in India have sophisticated algorithms that can determine stock prices by taking into consideration the trade volume, as the prices change very swiftly.

Conclusion

The Indian stock market is a dynamic platform where participants like SEBI, exchanges, brokers, and investors engage in trading. Understanding the key aspects, such as stock pricing, primary and secondary markets, and the role of brokers, is crucial for navigating the risks and rewards of stock market investments.